Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting-Reference-Cited by-同舟云学术

Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting

Published:2015-08-27 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zilbermintz Leeor,Leonardi William,Jeong Sun-Young,Sjodt Megan,McComb Ryan,Ho Chi-Lee C.,Retterer Cary,Gharaibeh Dima,Zamani Rouzbeh,Soloveva Veronica,Bavari Sina,Levitin Anastasia,West Joel,Bradley Kenneth A.,Clubb Robert T.,Cohen Stanley N.,Gupta Vivek,Martchenko Mikhail

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep13476.pdf

Reference46 articles.

1. Bekerman, E. & Einav S. Infectious disease. Combating emerging viral threats. Science 348, 282–283 (2015).

2. Martchenko, M., Jeong, S. Y. & Cohen, S. N. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Proc Natl Acad Sci USA 107, 15583–15588 (2010).

3. Chong, C. R., Chen, X., Shi, L., Liu, J. O. & Sullivan, D. J., Jr. A clinical drug library screen identifies astemizole as an antimalarial agent. Nature chemical biology 2, 415–416 (2006).

4. Sandvig, K. & van Deurs, B. Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther 12, 865–872 (2005).

5. Martchenko, M., Candille, S. I., Tang, H. & Cohen, S. N. Human genetic variation altering anthrax toxin sensitivity. Proc Natl Acad Sci USA 109, 2972–2977 (2012).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Clinical Outcomes of SARS‐CoV‐2 Drug Efficacy with a High‐Throughput Human Airway Microphysiological System;Advanced Biology;2024-08-09

2. A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquine;2023-06-28

3. Drug Delivery Options for Treatment of Ebola Infection;Viral Drug Delivery Systems;2023

4. C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus;iScience;2022-07

5. Association between oral antimalarial medication administration and mortality among patients with Ebola virus disease: a multisite cohort study;BMC Infectious Diseases;2022-01-20